Evolent Health, Inc. EVH

About Evolent Health, Inc. (EVH): stock profile, AI score and financials

Evolent Health, Inc. (EVH) stock profile, AI quality score, and SEC EDGAR financial data, a Technology sector company. 13F Pro's AI-powered ranking engine scores EVH at 26.0/100 on a composite quality score built from its SEC filings, placing it at rank #2,606 of 2,925 stocks — the bottom half of the AI-ranked universe. Areas of concern include balance sheet strength (9.9) and revenue growth (12.7), which score below median versus the broader universe. Shareholder dilution risk is elevated at 38.1/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Evolent Health, Inc. reports quarterly revenue of $652.5M, net income of $-28.4M, an operating margin of -1.5%. Top institutional holders of EVH by reported 13-F value include LINDEN ADVISORS, BlackRock, CADIAN CAPITAL MANAGEMENT, based on the most recent SEC filings. EVH trades on the NYSE exchange and files with the SEC under CIK 1628908. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate EVH daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Evolent Health, Inc. directly from SEC EDGAR.

Financials through the period ended Jun 30, 2026SEC EDGAR: CIK 1628908 →